Small Strongyles / Cyathostomins

Small strongyles, scientifically known as cyathostomins, represent the most prevalent and clinically significant internal parasite group affecting horses worldwide. This diverse group encompasses over 50 species of small nematodes that inhabit the large intestine, with virtually every grazing horse harboring some level of infection throughout their lifetime. Unlike the large strongyles that were historically considered the primary parasitic threat to horses, small strongyles have emerged as the dominant concern due to their unique ability to encyst within the intestinal wall and their widespread resistance to multiple classes of anthelmintic medications.

The prevalence of small strongyle infection approaches 100 percent in grazing horse populations globally, making them essentially ubiquitous parasites of equines. All horses with pasture access become exposed through ingestion of infective larvae from contaminated forage and soil. While adult worms residing in the intestinal lumen cause relatively mild pathology, the encysted larval stages embedded in the intestinal mucosa and submucosa pose the greater threat, capable of remaining dormant for months to years before mass emergence causes severe, potentially fatal disease.

The impact of small strongyle infection on horse health ranges from subclinical reduction in body condition to the life-threatening syndrome of larval cyathostominosis. Chronic infections contribute to poor coat quality, reduced performance, intermittent soft feces, and failure to maintain weight despite adequate nutrition. The catastrophic mass emergence of encysted larvae, though relatively uncommon, causes explosive diarrhea, rapid weight loss, protein loss, and carries mortality rates of up to 50 percent even with aggressive treatment. This biphasic nature of disease makes small strongyles simultaneously the most common and potentially most dangerous of equine parasites.

The widespread development of anthelmintic resistance in small strongyle populations has fundamentally transformed equine parasite management over the past several decades. Resistance to benzimidazole drugs is nearly universal, and resistance to pyrantel is common. Even the macrocyclic lactone drugs, once considered uniformly effective, now show reduced efficacy in some populations. This resistance crisis has driven the shift toward targeted selective treatment based on fecal egg counts rather than rotational deworming programs, emphasizing preservation of susceptible parasites and reduction of unnecessary drug exposure.

The primary cause of small strongyle infection is ingestion of infective third-stage larvae from pasture during grazing. Adult worms in the large intestine release eggs into feces, which develop through two larval stages in the environment before reaching the infective L3 stage. These larvae migrate onto grass blades, particularly during moist, mild conditions, where they await ingestion. Once consumed, larvae either develop directly to adult worms in the intestinal lumen or burrow into the intestinal wall to become encysted, where they may remain dormant for extended periods.

No breed predisposition exists for small strongyle infection, as all horses with pasture exposure become infected. However, individual horses demonstrate marked variation in their susceptibility to infection and their contribution to environmental contamination. Research has identified that approximately 20-30 percent of horses in any herd are responsible for 80 percent of egg shedding, making these high shedders the primary drivers of pasture contamination. This individual variation appears to have some genetic basis, though the specific mechanisms remain under investigation.

Environmental and management factors profoundly influence small strongyle transmission dynamics. Pasture contamination levels reflect stocking density, grazing management, and climate conditions. Larvae survive best in cool, moist conditions and are killed by extremes of heat, cold, or desiccation. Overgrazed pastures force horses to graze close to fecal piles where larval concentrations are highest. Lack of pasture rest periods or rotation maintains continuous transmission pressure. Spreading manure on pastures without composting recontaminates grazing areas.

Risk factors for clinical disease from small strongyles include young age, heavy exposure, and immunosuppression. Horses under five years of age have not yet developed full immunity and may harbor higher worm burdens. Newly introduced horses entering heavily contaminated pastures experience sudden high larval intake. Stress from transport, competition, breeding, or concurrent illness may precipitate mass larval emergence. Horses with heavy encysted larval burdens are at particular risk for larval cyathostominosis, especially during late winter and early spring when emergence naturally increases.

The pathophysiology of small strongyle infection involves both luminal and encysted stages causing distinct types of damage. Adult worms in the intestinal lumen feed on mucosal contents and cause superficial erosion, contributing to chronic inflammation, reduced nutrient absorption, and altered gut motility. Encysted larvae in the intestinal wall cause localized inflammation, granuloma formation, and mucosal disruption. Mass emergence of encysted larvae, the syndrome of larval cyathostominosis, produces severe inflammation, mucosal sloughing, loss of intestinal absorptive function, and protein-losing enteropathy that can prove rapidly fatal.

Early warning signs of small strongyle infection are often subtle and easily overlooked, as horses are prey animals that mask discomfort and many infections remain subclinical. Initial indicators may include a slightly dull hair coat, mild reduction in body condition despite adequate feeding, or occasional soft feces that resolve spontaneously. Some horses show decreased appetite for grain while continuing to eat hay normally. Performance may decline subtly, with horses tiring more easily or showing reduced enthusiasm for work. These nonspecific signs often go unattributed to parasitism without diagnostic testing.

Common symptoms of established chronic small strongyle infection reflect the ongoing intestinal inflammation and nutrient malabsorption caused by adult worms and low-level larval activity. Affected horses typically display poor coat quality with a rough, lackluster appearance even with appropriate grooming. Weight loss or difficulty maintaining condition occurs despite adequate caloric intake. Intermittent soft feces or mild diarrhea without obvious cause may be noted. Some horses develop edema of the lower legs or ventral abdomen due to protein loss. Reduced performance and stamina affect athletic horses.

Behavioral changes in horses with significant small strongyle burdens include decreased energy and willingness to work, mild depression or dullness, and reduced interest in social interactions with pasturemates. Some horses become more irritable or reactive, possibly reflecting low-grade abdominal discomfort. Appetite changes may manifest as picking at feed, eating slowly, or leaving grain while still consuming hay. Horses may show decreased interest in treats or supplements they previously enjoyed.

Physical signs observable on examination include poor body condition with visible ribs or spine despite adequate feeding, rough hair coat that fails to shed properly in spring, and pot-bellied appearance in some cases. Mild ventral or lower limb edema may be present. Fecal consistency ranges from normal to consistently soft or cow-pie like. Mucous membranes are usually normal unless anemia has developed in severe cases. Rectal temperature is typically normal in uncomplicated infections.

Symptom progression in untreated or inadequately controlled infections follows a gradual decline in condition over months to years, punctuated by potential acute crises. Chronic infections slowly worsen body condition and coat quality. The development of larval cyathostominosis represents acute, dramatic deterioration with sudden onset of profuse watery diarrhea, rapid weight loss, fever, and signs of colic or abdominal pain. This syndrome typically occurs in late winter or early spring and carries grave prognosis, with mortality approaching 50 percent even with intensive treatment.

Emergency symptoms requiring immediate veterinary care include explosive diarrhea with watery feces projecting from the rectum, rapid weight loss over days rather than weeks, fever, signs of colic or severe abdominal pain, severe depression or weakness, and dehydration with tacky mucous membranes or prolonged skin tent. Larval cyathostominosis is a medical emergency requiring hospitalization and intensive supportive care. Any horse showing sudden severe diarrhea, particularly during late winter or spring, should be evaluated urgently for this potentially fatal syndrome.

Physical examination of horses suspected of small strongyle-related disease begins with thorough assessment of body condition, hydration status, and vital parameters. Weight estimation or measurement provides baseline data for monitoring. Coat quality, presence of edema, and overall thriftiness are evaluated. Abdominal auscultation assesses gut sounds, which may be increased, decreased, or abnormal in character depending on infection severity and complications. Rectal examination in adult horses may reveal abnormal fecal consistency or, rarely, thickened intestinal walls in severe cases. Complete evaluation helps distinguish parasitism from other causes of weight loss or diarrhea.

Fecal egg count using quantitative flotation techniques forms the cornerstone of small strongyle diagnosis and monitoring. The McMaster or modified Wisconsin technique provides eggs per gram measurements indicating the magnitude of adult worm egg production. However, interpretation requires understanding that egg counts do not detect encysted larvae, the most dangerous life stage. Low or negative egg counts do not rule out significant encysted burdens. Egg counts are most valuable for identifying high-shedding horses contributing disproportionately to pasture contamination and for monitoring treatment efficacy through fecal egg count reduction testing.

Advanced diagnostics become necessary when larval cyathostominosis is suspected or when standard testing fails to explain clinical signs. Blood work may reveal hypoproteinemia and hypoalbuminemia reflecting intestinal protein loss, elevated white blood cell counts with neutrophilia, and mild anemia in severe cases. Abdominal ultrasound can demonstrate thickened large intestinal walls, increased peritoneal fluid, or other abnormalities. Absorption tests assess intestinal function. Unfortunately, no reliable antemortem test exists for quantifying encysted larval burdens, making clinical assessment and history essential for diagnosis. Rectal biopsy showing encysted larvae provides definitive diagnosis but is rarely performed.

Differential diagnosis for horses presenting with weight loss, poor condition, or diarrhea encompasses numerous conditions beyond small strongyle infection. Dental disease limiting feed intake and digestion must be evaluated. Other parasites including tapeworms and large strongyles may cause similar signs. Sand enteropathy affects horses in sandy soil regions. Inflammatory bowel disease, intestinal lymphoma, and other infiltrative diseases cause chronic weight loss and malabsorption. Right dorsal colitis from NSAID use produces similar clinical pictures. Infectious causes of diarrhea including salmonellosis require consideration. Comprehensive evaluation ensures appropriate treatment.

Immediate treatment of uncomplicated small strongyle infection focuses on reducing adult worm burdens and addressing clinical signs. Unlike the concerns with ascarid impaction, treatment of small strongyles rarely causes acute complications from worm die-off. However, it is essential to recognize that no currently available treatment reliably kills encysted larvae, meaning that clinical disease from larval emergence may occur despite successful treatment of luminal adults. Initial treatment decisions balance the need for worm reduction against preservation of drug efficacy through targeted use.

Medical management of small strongyles must account for widespread anthelmintic resistance that renders many drugs partially or completely ineffective. Resistance to benzimidazoles including fenbendazole and oxibendazole is nearly universal and renders these drugs essentially useless against small strongyles on most farms. Pyrantel resistance is common and increasing. Macrocyclic lactones including ivermectin and moxidectin retain efficacy on most farms but show shortened egg reappearance periods indicating developing resistance. Treatment selection should be based on farm-specific fecal egg count reduction testing rather than assumptions about drug efficacy.

For treatment of encysted larvae, only the larvicidal dose of fenbendazole at 10 mg/kg daily for five consecutive days and moxidectin at the standard dose of 0.4 mg/kg demonstrate activity against inhibited larvae, though neither achieves complete elimination. Moxidectin is generally preferred when larvicidal treatment is needed due to widespread fenbendazole resistance affecting even the larvicidal protocol. The timing of larvicidal treatment is debated, with some advocating routine late fall or early winter treatment to reduce encysted populations before spring emergence risk peaks.

Supportive care for horses with larval cyathostominosis constitutes the primary treatment for this acute syndrome, as antiparasitic drugs cannot rapidly reverse the inflammatory cascade triggered by mass larval emergence. Hospitalization with intensive monitoring is typically required. Intravenous fluid therapy corrects dehydration and electrolyte abnormalities. Plasma transfusion or synthetic colloid administration addresses hypoproteinemia. Anti-inflammatory therapy including corticosteroids may reduce intestinal inflammation. Nutritional support through parenteral feeding may be necessary when oral intake is impossible. Despite intensive treatment, mortality remains high.

Rehabilitation following treatment of uncomplicated small strongyle infection proceeds with monitoring for egg reappearance through regular fecal testing. Horses showing good treatment response typically demonstrate negative or very low egg counts at the two-week post-treatment check. Gradual return to normal management and turnout proceeds once immediate concerns have resolved. Nutritional optimization supports condition recovery. Horses that have survived larval cyathostominosis require extended convalescence with gradual refeeding and may have lasting intestinal damage affecting long-term digestion.

Treatment decision factors include the horse's current clinical status, fecal egg count results, farm-specific resistance data, season, and management context. Treating only horses with fecal egg counts above threshold levels, typically 200-500 eggs per gram, reduces unnecessary drug exposure and preserves susceptible parasite refugia on pasture. However, this approach does not address encysted larvae, requiring additional consideration of larvicidal treatment timing. Competition horses face drug withdrawal time requirements. Cost considerations are balanced against the expense of treating clinical disease that results from inadequate control.

Recovery timelines for horses treated for small strongyle infection vary based on the severity of clinical signs and whether complications have occurred. Horses with uncomplicated chronic infections typically show gradual improvement in coat quality and body condition over several weeks to months following effective treatment and appropriate nutritional management. Complete resolution of weight loss may require three to six months of consistent care. Horses recovering from larval cyathostominosis face prolonged convalescence of months, with some never fully regaining normal intestinal function.

Post-treatment care and monitoring center on confirming treatment efficacy and managing ongoing parasite exposure. Fecal egg count reduction testing performed 10-14 days after treatment quantifies the percentage reduction achieved, with less than 90-95% reduction suggesting resistance concerns. Egg reappearance period monitoring tracks how quickly counts return to pre-treatment levels, with shortened intervals indicating reduced drug efficacy. Regular fecal testing at two to three-month intervals guides subsequent treatment decisions. Body condition and coat quality are monitored as indicators of overall health.

Prognosis factors influencing recovery include the severity of initial disease, the presence of encysted larval burdens, response to treatment, and ongoing management quality. Horses treated before significant weight loss and intestinal damage develop carry excellent prognosis for full recovery. Those with heavy encysted burdens remain at risk for larval cyathostominosis regardless of luminal worm control. Horses surviving larval cyathostominosis have guarded long-term prognosis due to potential permanent intestinal damage. Farm management practices significantly influence reinfection pressure and long-term outcomes.

Long-term outlook for horses with small strongyle exposure, which includes essentially all grazing horses, depends on implementation of sustainable parasite management programs. Complete elimination of small strongyles is neither achievable nor desirable, as maintaining susceptible parasite populations in refugia slows resistance development. Instead, the goal is maintaining parasite burdens below clinically significant levels while preserving anthelmintic efficacy for future use. Horses managed with targeted selective treatment based on individual fecal egg counts can maintain health and performance throughout their lives despite ongoing low-level infection.

Management practices for small strongyle prevention emphasize reducing pasture contamination and minimizing infective larvae ingestion. Regular manure removal from pastures, ideally twice weekly, removes eggs before they develop into infective larvae. Pasture rotation with rest periods of at least three to six months allows larval populations to decline, though larvae can survive for extended periods under favorable conditions. Cross-grazing with cattle or sheep, which do not harbor equine small strongyles, reduces pasture larval loads as these animals consume and destroy larvae without becoming infected. Avoiding overstocking prevents forced grazing near fecal deposits where larval concentrations peak.

Nutritional prevention supports immune system competence and overall health, reducing the impact of parasitism that cannot be entirely prevented. Horses maintained in good body condition on balanced diets demonstrate better resistance to clinical disease despite infection. Ensuring adequate protein intake supports intestinal repair and immune function. Stress reduction through appropriate management minimizes immunosuppression that may precipitate larval emergence. While nutrition cannot prevent infection, well-nourished horses better tolerate parasite challenges.

Exercise and conditioning considerations relate to pasture management rather than direct exercise effects on parasitism. Horses kept in stalls with limited turnout experience reduced exposure but face other health compromises from restricted movement. Strategic use of sacrifice paddocks or dry lots during peak larval availability periods, typically moist spring and fall conditions, reduces exposure while maintaining some turnout opportunity. Balancing pasture access for behavioral and physical health against parasite exposure requires thoughtful management.

Environmental factors significantly influence small strongyle transmission risk. Climate conditions affect larval development and survival, with larvae most abundant during moist, mild weather and reduced during temperature extremes or drought. Understanding local seasonal patterns helps time strategic management interventions. Pasture drainage affects moisture levels influencing larval survival. Harrowing pastures during hot, dry weather may desiccate and kill larvae, but harrowing during moist conditions simply spreads contamination. Composting manure at high temperatures kills eggs and larvae before pasture application.

Deworming protocols have evolved toward targeted selective treatment based on fecal egg counts, departing from historical rotational deworming programs that accelerated resistance development. Under this approach, only horses with fecal egg counts exceeding threshold levels, typically 200-500 eggs per gram, receive treatment, while low shedders remain untreated. This maintains refugia of susceptible parasites on pasture, diluting resistant populations and slowing resistance spread. Drug selection is based on farm-specific efficacy testing rather than rotation schedules. Larvicidal treatments for encysted stages are reserved for strategic timing or horses at high risk. New arrivals should be quarantined, tested, and treated before pasture access.

Daily management for horses living with small strongyle exposure, which includes virtually all grazing horses, integrates parasite awareness into routine care without requiring dramatic lifestyle changes. Regular observation during daily feeding and handling identifies subtle condition changes that may indicate increasing parasite burdens. Periodic body condition scoring, ideally monthly, tracks trends that might otherwise go unnoticed. Manure consistency and characteristics provide information about intestinal health. Attention to coat quality, energy levels, and appetite during daily interactions supports early problem detection.

Housing and turnout decisions balance the benefits of pasture access against parasite exposure risks. Complete prevention of small strongyle infection requires permanent stall housing without pasture access, a management approach that creates other significant health and welfare concerns. More practical approaches include strategic use of pasture rotation, temporary sacrifice lot housing during peak larval availability, and maintenance of stocking densities that prevent overgrazing. Dry lot feeding may reduce exposure while still allowing outdoor access. Housing new arrivals separately during quarantine periods prevents introduction of resistant parasite strains.

Exercise modifications are generally unnecessary for horses with controlled small strongyle infection, as routine infections do not directly limit athletic performance. However, horses with clinical disease including weight loss, diarrhea, or protein-losing enteropathy require reduced work demands during recovery. Exercise intensity should be moderated for horses in poor condition until body condition improves. Return to full athletic activity proceeds as health allows, guided by veterinary assessment. Horses competing at high levels may benefit from strategic treatment timing to optimize condition during competition seasons.

Monitoring and ongoing care for small strongyle management relies heavily on regular fecal egg count testing, typically performed every two to four months for horses in active parasite management programs. Results guide individual treatment decisions and identify changes in shedding patterns. Annual or semi-annual fecal egg count reduction testing following treatment monitors drug efficacy on the farm. Body condition, coat quality, and performance are tracked as clinical indicators. Records of testing results, treatments, and responses over time inform management refinements.

Quality of life and use considerations for horses managed for small strongyle infection are generally favorable, as sustainable management programs maintain health without imposing severe restrictions. Horses can continue normal athletic careers, breeding activities, and pleasure use with appropriate monitoring and treatment. The primary considerations involve time and expense for regular fecal testing, with associated treatment costs for horses requiring intervention. Proactive management prevents the catastrophic consequences of larval cyathostominosis while preserving drug options for future use. Investment in good parasite management supports long-term horse health and welfare.

Small strongyle infection demonstrates no breed predisposition, affecting all horses, ponies, donkeys, and mules that have pasture exposure regardless of their genetic background. The universal susceptibility reflects the long co-evolutionary history between equids and these parasites, with all equine species serving as suitable hosts. Thoroughbreds, Quarter Horses, Warmbloods, Arabians, draft breeds, and ponies of all types face equivalent infection risk given similar exposure conditions. The determining factors for infection and disease relate to management and individual variation rather than breed genetics.

Use and discipline considerations influence small strongyle risk primarily through management intensity and pasture access patterns. Horses maintained on intensive training programs with limited turnout may have reduced exposure but still acquire infection during any pasture access. Breeding operations with mares and foals on pasture face continuous transmission pressure. Trail and pleasure horses with regular pasture turnout have ongoing exposure. Sport horses may experience variable risk depending on their home management and competition travel. All use categories benefit from regular fecal monitoring and targeted treatment programs.

Genetic testing and breeding recommendations for small strongyle susceptibility represent an area of ongoing research rather than current practical application. Studies have identified significant individual variation in fecal egg shedding with apparent heritability, suggesting genetic components to resistance or tolerance. However, no commercial genetic tests currently exist to identify susceptible versus resistant individuals. Future breeding programs might incorporate parasite resistance traits alongside other selection criteria. Currently, recommendations focus on identifying high-shedding individuals through repeated fecal testing and managing accordingly rather than making breeding decisions based on parasite susceptibility.

Commonly co-occurring conditions with small strongyle infection include other parasitic infestations that share pasture transmission pathways. Tapeworms frequently coexist with small strongyles and may contribute to colic risk, particularly ileal impaction. Large strongyles, though now less common due to effective control, may be present on some farms. Bots affect most pastured horses seasonally. Other gastrointestinal conditions including gastric ulcers occur commonly in managed horses and may compound the effects of parasitism. Nutritional deficiencies may develop secondary to chronic parasitism and malabsorption.

Conditions with similar symptoms requiring differentiation span a wide range of gastrointestinal and systemic diseases. Weight loss and poor condition may result from dental disease, other parasites, chronic infection, neoplasia, or inadequate nutrition. Diarrhea has numerous potential causes including sand enteropathy, right dorsal colitis, inflammatory bowel disease, and infectious agents such as Salmonella. Protein-losing enteropathy occurs in various intestinal diseases beyond parasitism. Distinguishing larval cyathostominosis from other causes of acute severe diarrhea requires careful clinical assessment, as treatments differ significantly.

Potential complications of small strongyle infection center primarily on the syndrome of larval cyathostominosis, representing mass emergence of encysted larvae with severe inflammatory response. This syndrome causes profuse watery diarrhea, rapid weight loss, hypoproteinemia, and death in approximately 50 percent of affected horses despite treatment. Survivors may have permanent intestinal damage affecting digestion and absorption. Chronic infection contributes to long-term poor condition and may predispose to other health problems through immune system effects and nutritional compromise. Anthelmintic resistance development complicates future treatment options for affected horses and entire farm populations.